AiekensB., NiermanR., ShindlerE.: Investigation of the depth of penetration into the normal bladder tumors of locally instilled Mitomycin C therapy and prophylaxis of superficial bladder carcinomas, p. 37–42. Thieme Verlag, Stuttgart 1985.
2.
DaskalY., SolowayM. S., De FuriaM.D., CrookeS.T.: Morphological effects of Mitomycin C administered intravesically to normal mice with N (4–5) nitro, 2-furyl, 2-thiazolyl, foramide induced bladder neoplasms. Cancer Res., 40; 261 (1980).
3.
EbnerH., PustR., BeckerR., KraushaarJ.: Cytological and impulsecytophometric therapy control and diagnosis of recurrences in bladder carcinomas during adjuvant chemiotherapy, p. 37–52. HulandH. (ed.), Thieme Verlag, Stuttgart1985.
4.
ForniA.: Possibilità e limiti della citologia urinaria per la diagnosi precoce dei tumori uroteliali professionali. Atti XXI Conv.Urologi Lombardi, Milano1982.
5.
MishinaT., OdaK., MurataS., OoeF., MoriY., TakahashiT.: Mitomycin C bladder instillation therapy for bladder tumors. J. Urol., 114; 217 (1975).
6.
MurphyW. M., SolowayM. S., CrabtreeW. N.: The morphological effects of Mitomycin C in mammalian urinary bladder. Cancer, 47; 2567 (1981).
7.
NissenkornI., HerrodH., SolowayM. S.: Side effects associated with intravesical Mitomycin C. J. Urol., 126; 596 (1981).
8.
ShidaK., DoguchiT., SazakiT., SatoH., TakahashiU., TataniM., KatoH., UranoE., OogoshiM., OzekaZ., YajiamaH., NakagamiY., NakamuraY.: Treatment of the bladder cancer with instillations of Mitomycin C (first report). Jap. J. Clin. Urol., 21; 1057 (1967).
9.
SolowayM. S.: Treatment of superficial bladder cancer with intravesical Mitomycin C.: analysis of immediate and long-term response in 70 patients T. Urol., 134; 1107 (1985).
10.
WajsmanZ., DhafirR. A., McDonaldS., BlockA., DragoneN., PontesJ. E.: Studies of Mitomycin C absorption after intravesical treatment of superficial bladder tumors. J. Urol., 132; 30 (1984).
